CompaniesAdaptive Phage Therapeutics

Adaptive Phage Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

42

By Phase

PHASE2: 2PHASE1/PHASE2: 3

By Status

WITHDRAWN: 3TERMINATED: 2NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04287478
NCT05177107
NCT05269121
NCT04787250
NCT05269134
Hover over trial bars to see details

Recent Trials

NCT05269134Lead Sponsor
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
PHASE2Withdrawn
Started: Mar 27, 2023 · Completed: Jul 31, 2027
NCT04787250Lead Sponsor
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
PHASE1/PHASE2Withdrawn
Started: Oct 31, 2022 · Completed: May 31, 2024
NCT05269121Lead Sponsor
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
PHASE1/PHASE2Withdrawn
Started: Sep 30, 2022 · Completed: Nov 30, 2024
NCT05177107Lead Sponsor
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
PHASE2Terminated
41 participants
Started: Nov 24, 2021 · Completed: May 30, 2025
NCT04287478Lead Sponsor
Bacteriophage Therapy in Patients With Urinary Tract Infections
PHASE1/PHASE2Terminated
1 participants
Started: Dec 9, 2020 · Completed: Feb 28, 2023
View all 6 trials →
Funding History (8)
D
Jun 9, 2023
Filing
D
May 20, 2021
Filing
D/A
Aug 27, 2020
Filing
D
Aug 24, 2020
Filing
D
Jun 22, 2020
Filing
D/A
Nov 27, 2019
Filing
D
Jun 5, 2018
Filing
D
Apr 14, 2017
Filing
Related Companies
Biomx
acquired